Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01867398 · ClinicalTrials.gov registry record

Effects of Atypical Antipsychotics on Brain Function in Children and Teens With Conduct Disorders

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Terminated
Registry status
12
Enrollment target

NCT01867398 is a clinical trial that was terminated before completion, run by National Institute of Mental Health (NIMH). The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01867398 was terminated before completion, sponsored by National Institute of Mental Health (NIMH).

TERMINATED
Registry status
12 participants
Enrollment target

Study Summary

Background: \- Some children and teenagers have conditions known as conduct disorders. They often have long-term chronic behavior problems, such as defiant behavior or violence. Conduct disorders are often treated with antipsychotic medication. Researchers want to study two types of newer antipsychotics (aripiprizole and risperidone) for children and adolescents with conduct disorders. They will look at how these drugs affect brain activity. To do so, they will give brain activity tests using magnetic resonance imaging (MRI). The tests will compare the results from healthy volunteer children and teens to those of others with behavior problems. Objectives: \- To see how atypical antipsychotics affect brain activity of children and teenagers with conduct disorders. Eligibility: * Children and teenagers between 10 and 18 years of age who have a conduct disorder and are taking aripiprizole. * Children and teenagers between 10 and 18 years of age who have a conduct disorder and are taking risperidone. * Children and teenagers between 10 and 18 years of age who have a conduct disorder and are not taking an atypical antipsychotic. * Healthy volunteers between 10 and 18 years of age. Design: * Participants will be screened with a physical exam and medical history. Parents/guardians will be asked questions about their child s feelings, experiences, and behavior. Participants will also answer questions about their feelings and moods. * This study will involve two visits. Each visit will involve MRI scanning. * At the first visit, participants will have memory and thinking tests. The tests will involve making decisions or playing games. Some of these tests will use MRI scanning to look at brain activity. * The second visit will be 3 to 5 months after the first visit. The tests from the first visit will be repeated.

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2013-04-29
Est. Completion 2015-05-18

What the Registry Record Tells You About NCT01867398

The ClinicalTrials.gov registry entry for NCT01867398 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01867398 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01867398 about?

NCT01867398 is a clinical study titled "Effects of Atypical Antipsychotics on Brain Function in Children and Teens With Conduct Disorders". Background: \- Some children and teenagers have conditions known as conduct disorders. They often have long-term chronic behavior problems, such as defiant behavior or violence. Conduct disorders are often treated with antipsychotic medication. Researchers want to study two types of newer antipsych...

What is the current status of trial NCT01867398?

This trial is currently terminated. The enrollment target is 12 participants. The study started on 2013-04-29. Estimated completion is 2015-05-18.

Who is sponsoring clinical trial NCT01867398?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.